Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
92.68
+6.68 (7.77%)
At close: Nov 14, 2025, 4:00 PM EST
93.99
+1.31 (1.41%)
After-hours: Nov 14, 2025, 7:59 PM EST
Celcuity Market Cap
Celcuity has a market cap or net worth of $4.29 billion as of November 14, 2025. Its market cap has increased by 627.96% in one year.
Market Cap
4.29B
Enterprise Value
4.15B
1-Year Change
627.96%
Ranking
Category
Stock Price
$92.68
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $4.29B, an increase of 3,102.70%. That is a compound annual growth rate of 52.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 3.65B | 650.76% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |